Analgesia induced by morphine microinjected into the nucleus raphe magnus: effects on tonic pain

Christian Dualé1, Fernando Sierralta, Radhouane Dallel

  • 1INSERM, E216, Clermont-Ferrand, F-63000, France. cduale@chu-clermontferrand.fr

Current Drug Delivery
|July 14, 2007
PubMed

Insights

Morphine in the Nucleus Raphe Magnus provides analgesia for both transient and tonic pain in rats. However, its effect on tonic pain is not complete, suggesting other sites of action for morphine-induced analgesia.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • The Nucleus Raphe Magnus is a potential site for morphine's analgesic effects, demonstrated in transient pain models.
  • Investigating morphine's action in the Nucleus Raphe Magnus is crucial for understanding pain management.

Purpose of the Study:

  • To determine if morphine administered to the Nucleus Raphe Magnus exhibits analgesic properties in a tonic pain model.
  • To compare the analgesic efficacy of morphine in the Nucleus Raphe Magnus for both phasic and tonic pain stimuli.

Main Methods:

  • Microinjection of morphine (5 microg) or saline into the Nucleus Raphe Magnus of rats.
  • Assessment of analgesic effects using tail-flick test (phasic pain) and formalin injection in the orofacial region (tonic pain).

Main Results:

  • Morphine in the Nucleus Raphe Magnus significantly reduced the tail-flick response, indicating strong analgesia in phasic pain.
  • Analgesia was observed for both early and late phases of the formalin test (tonic pain), though not completely abolishing the response.
  • Statistical significance was noted for tail-flick (p <0.0001), early formalin (p = 0.007), and late formalin responses (p = 0.02).

Conclusions:

  • The Nucleus Raphe Magnus plays a role in morphine-induced analgesia for both transient and tonic pain.
  • The incomplete blunting of the tonic pain response suggests that the Nucleus Raphe Magnus is not the sole site of action for morphine's clinical analgesic effects.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...